Axol Bioscience acquires Newcells Biotech ophthalmology unit

18th February 2026 Uncategorised 0

Move expands iPSC‑derived retinal model portfolio and strengthens position in research

More: Axol Bioscience acquires Newcells Biotech ophthalmology unit
Source: News